The country’s leading quoted CBD wellness and medicinal cannabis group
Latest updates
Sativa Group Plc [AQSE: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis Group, is working on its Novel Food application in partnership with Stillcanna Inc, and is committed to meeting the requirements of the Food Standards Agency (“FSA”) concerning the safe use of CBD products and the timetable for Novel Food authorisation.
Sativa Group Plc (AQSE: SATI), the UK’s leading quoted CBD wellness and medicinal cannabis company, announces that certain options having reverted back to Geremy Thomas from former employees of the Group, having lapsed due to vesting conditions not having been met, have been re-surrended so that 3,076,923 options have been issued to Joseph Colliver, Chief Financial Officer of Sativa, and 1,333,333 options have been issued to Anne Tew, Company Secretary of Sativa.
Further to the announcement made by the Company on 3 June 2020 (the “Rule 2.7 Announcement”), Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, confirms that is has yesterday, 22 June, issued a Part 8 Claim Form dated 22 June 2020 in the Companies Court for an Order under Section 896 of the Companies Act 2006 to convene on 14 August 2020 at 11 a.m…
Goodbody Botanicals is aimed at the UK’s major grocers, high street pharmacies and retailers, as well as independent pharmacies throughout the country. The brand and packaging is seen as industry-leading by numerous retailers.
Goodbody Wellness focuses on the health and beauty markets. The brand sells products to specialty retailers as well as through three company-owned Goodbody Wellness stores.
Tessellate Collective sells CBD products through the direct marketing channel.
PhytoVista Laboratories is a leading UK testing laboratory for cannabis-based CBD products.
